Tempest Therapeutics, Inc.
TPST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $25,860 | $32,967 | $302,734 |
| - Cash | $7,514 | $14,280 | $21,511 | $30,268 |
| + Debt | $7,258 | $8,663 | $13,105 | $15,365 |
| Enterprise Value | – | $20,243 | $24,561 | $287,831 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$66 | -$67 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,445 | -$7,757 | -$10,631 | -$13,517 |
| % Margin | – | – | – | – |
| Net Income | -$3,511 | -$7,870 | -$10,860 | -$13,813 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.79 | -2.07 | -3.16 | -0.5 |
| % Growth | 61.8% | 34.5% | -532% | – |
| Operating Cash Flow | -$6,779 | -$8,431 | -$8,036 | -$10,149 |
| Capital Expenditures | $0 | $0 | $0 | -$3 |
| Free Cash Flow | -$6,779 | -$8,431 | -$8,036 | -$10,152 |